Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 50 (3), 425-8

Pharmacodynamics of Cefepime in Patients With Gram-negative Infections

Affiliations

Pharmacodynamics of Cefepime in Patients With Gram-negative Infections

Vincent H Tam et al. J Antimicrob Chemother.

Abstract

We conducted a prospective, open-label study to delineate a relationship between exposure and outcomes in 36 patients treated with cefepime. Twenty patients had documented Gram-negative infections. Timed blood and urine samples were obtained at steady state to determine pharmacokinetic and pharmacodynamic parameters. Microbiological success was significantly correlated with the proportion of the dosing interval that cefepime concentrations exceeded 4.3 x MIC. Our results support in vitro data that suggest bactericidal activity of beta-lactams is optimized at concentrations approximately 4 x MIC. These results should be validated by large prospective clinical trials.

Similar articles

See all similar articles

Cited by 52 articles

See all "Cited by" articles

Publication types

MeSH terms

Feedback